Ritz E, Bergis K, Strojek K, Keller C
Medizinische Universitätsklinik Heidelberg.
Med Klin (Munich). 1997 Jul 15;92(7):421-5. doi: 10.1007/BF03042574.
In Germany nephropathy in patients with type II diabetes has become the most frequent single cause of uremia requiring renal replacement therapy. This calls for effective measures of prevention.
In patients with established diabetic nephropathy, hypertension is the most important pathogenetic factor which is susceptible to therapeutic intervention. Some pathogenetic mechanisms are discussed which impact on antihypertensive therapy. Interaction between hypertension and diabetic nephropathy is analyzed.
Diabetic nephropathy in patients with type II diabetes has become the most frequent cause of endstage renal failure in Germany. Preventive measures, i. e. near normal glycemia and particularly antihypertensive treatment, have been proven to interfere with progression of renal failure in diabetic nephropathy. Early recognition is possible by testing for urinary albumin (microalbuminuria). In patients with diabetic nephropathy, blood pressure should be lowered to values well within the range of normotension by dietary salt restriction and antihypertensive drug therapy.
在德国,II型糖尿病患者的肾病已成为需要肾脏替代治疗的尿毒症最常见的单一病因。这就需要采取有效的预防措施。
在已确诊糖尿病肾病的患者中,高血压是最重要的致病因素,且易于进行治疗干预。文中讨论了一些影响抗高血压治疗的致病机制。分析了高血压与糖尿病肾病之间的相互作用。
在德国,II型糖尿病患者的糖尿病肾病已成为终末期肾衰竭最常见的病因。预防措施,即血糖接近正常水平,尤其是抗高血压治疗,已被证明可干预糖尿病肾病患者肾衰竭的进展。通过检测尿白蛋白(微量白蛋白尿)可实现早期识别。对于糖尿病肾病患者,应通过限制饮食中的盐摄入和抗高血压药物治疗,将血压降至正常血压范围内的理想水平。